Literature DB >> 1993057

The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes.

W C Sessa1, S Kaw, M Hecker, J R Vane.   

Abstract

Human polymorphonuclear leukocytes (PMNs) converted human big endothelin (bET; 2 microM) to an endothelin-1 (ET-1) like contractile factor, as assessed by bioassay. The generation of this ET-1 like activity was rapid (minutes), time-dependent and more pronounced in non-activated cells, suggesting a partial degradation by activated PMNs. Phosphoramidon (54 micrograms/ml) inhibited the formation of this contractile factor, whereas phenylmethylsulfonylfluoride (PMSF; 25 micrograms/ml), pepstatin A (1 microgram/ml) or epoxysuccinyl-L-leucylamido-(guanidino)butane (E-64; 10 micrograms/ml) did not. Incubations of activated PMNs with PMSF significantly potentiated the generation of ET-1 like activity and selectively inhibited the degradation of [125I]ET-1 by activated PMNs. These findings indicate that human PMNs contain and/or release neutral proteases, which can both rapidly produce and degrade ET-1, an observation which may have important (patho)physiologic implications.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1993057     DOI: 10.1016/0006-291x(91)91461-k

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  29 in total

Review 1.  Endothelin-1 and its role in the pathogenesis of infectious diseases.

Authors:  Brandi D Freeman; Fabiana S Machado; Herbert B Tanowitz; Mahalia S Desruisseaux
Journal:  Life Sci       Date:  2014-04-26       Impact factor: 5.037

2.  [Pathomorphology of coronary atherosclerosis].

Authors:  C Ihling
Journal:  Herz       Date:  1998-03       Impact factor: 1.443

3.  Inhibition of granulocyte-derived proteases reduces the increase in plasma endothelin associated with myocardial ischemia in the pig.

Authors:  T Tønnessen; A Ilebekk; P A Naess; G Christensen
Journal:  Basic Res Cardiol       Date:  1996 Jul-Aug       Impact factor: 17.165

4.  Association of endothelin with lung hemorrhage induced by immune complexes in rats.

Authors:  C F P Teixeira; S Jancar; W T Lima; P D'Orléans-Juste; P Sirois
Journal:  Inflammation       Date:  2004-10       Impact factor: 4.092

5.  Proceedings of the 4th International Symposium on Mechanisms of Secondary Brain Damage -- an update. Abstracts.

Authors: 
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

6.  Expression of vasoactive mediators during mechanical ventilation in nitrofen-induced diaphragmatic hernia in rats.

Authors:  Toko Shinkai; Hideki Shima; Valeria Solari; Prem Puri
Journal:  Pediatr Surg Int       Date:  2004-11-26       Impact factor: 1.827

7.  Granulocyte-macrophage colony-stimulating factor and interleukin-3 potentiate interferon-gamma-mediated endothelin production by human monocytes: role of protein kinase C.

Authors:  B Salh; K Hoeflick; W Kwan; S Pelech
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

8.  Targeting endothelin ETA and ETB receptors inhibits antigen-induced neutrophil migration and mechanical hypernociception in mice.

Authors:  Waldiceu A Verri; Thiago M Cunha; Danilo A Magro; Ana T G Guerrero; Silvio M Vieira; Vanessa Carregaro; Guilherme R Souza; Maria das Graças M O Henriques; Sérgio H Ferreira; Fernando Q Cunha
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-10-15       Impact factor: 3.000

9.  Trypanosoma cruzi infection activates extracellular signal-regulated kinase in cultured endothelial and smooth muscle cells.

Authors:  Shankar Mukherjee; Huan Huang; Stefka B Petkova; Chris Albanese; Richard G Pestell; Vicki L Braunstein; George J Christ; Murray Wittner; Michael P Lisanti; Joan W Berman; Louis M Weiss; Herbert B Tanowitz
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

Review 10.  The role of endothelin-1 in the pathogenesis of idiopathic pulmonary fibrosis.

Authors:  Jeffrey J Swigris; Kevin K Brown
Journal:  BioDrugs       Date:  2010-02-01       Impact factor: 5.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.